Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreia Valente

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Bioinorganic Chemistry and Applications|October 9, 2023
Evaluation of the Antiproliferative Properties of CpRu Complexes Containing N-Methylated Triazaphosphaadamantane DerivativesAndres Alguacil, Franco Scalambra, Antonio Romerosa, et al.
Journal of Inorganic Biochemistry|January 4, 2011
DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligandsVirtudes Moreno, Mercè Font-Bardia, Teresa Calvet, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|February 25, 2014
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexesLeonor Côrte-Real, Filipa Mendes, Joana Coimbra, et al.
Dalton Transactions (Cambridge, England : 2003)|November 6, 2025
Lysosome-targeted Ru(II)-cyclopentadienyl organometallic anticancer complexesRicardo G Teixeira, Lívia Stenico, Xavier Fontrodona, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 6, 2021
Anticancer Activity and In Vitro to In Vivo Mechanistic Recapitulation of Novel Ruthenium-Based Metallodrugs in the Zebrafish ModelBrittany F Karas, Jordan M Hotz, Brian M Gural, et al.
Journal of Inorganic Biochemistry|July 8, 2015
The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compoundsLeonor Côrte-Real, M Paula Robalo, Fernanda Marques, et al.
European Journal of Medicinal Chemistry|December 23, 2018
Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligandLeonor Côrte-Real, Brittany Karas, Patrícia Gírio, et al.
Pharmacological Research|August 19, 2024
A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compoundIris C Salaroglio, Denitsa Stefanova, Ricardo G Teixeira, et al.
European Journal of Medicinal Chemistry|December 5, 2017
Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cellsRicardo G Teixeira, Ana Rita Brás, Leonor Côrte-Real, et al.
Inorganic Chemistry|June 27, 2019
Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological EffectLeonor Côrte-Real, Brittany Karas, Ana Rita Brás, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Bioinorganic Chemistry and Applications|October 9, 2023
Evaluation of the Antiproliferative Properties of CpRu Complexes Containing N-Methylated Triazaphosphaadamantane DerivativesAndres Alguacil, Franco Scalambra, Antonio Romerosa, et al.
Journal of Inorganic Biochemistry|January 4, 2011
DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligandsVirtudes Moreno, Mercè Font-Bardia, Teresa Calvet, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|February 25, 2014
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexesLeonor Côrte-Real, Filipa Mendes, Joana Coimbra, et al.
Dalton Transactions (Cambridge, England : 2003)|November 6, 2025
Lysosome-targeted Ru(II)-cyclopentadienyl organometallic anticancer complexesRicardo G Teixeira, Lívia Stenico, Xavier Fontrodona, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 6, 2021
Anticancer Activity and In Vitro to In Vivo Mechanistic Recapitulation of Novel Ruthenium-Based Metallodrugs in the Zebrafish ModelBrittany F Karas, Jordan M Hotz, Brian M Gural, et al.
Journal of Inorganic Biochemistry|July 8, 2015
The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compoundsLeonor Côrte-Real, M Paula Robalo, Fernanda Marques, et al.
European Journal of Medicinal Chemistry|December 23, 2018
Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligandLeonor Côrte-Real, Brittany Karas, Patrícia Gírio, et al.
Pharmacological Research|August 19, 2024
A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compoundIris C Salaroglio, Denitsa Stefanova, Ricardo G Teixeira, et al.
European Journal of Medicinal Chemistry|December 5, 2017
Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cellsRicardo G Teixeira, Ana Rita Brás, Leonor Côrte-Real, et al.
Inorganic Chemistry|June 27, 2019
Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological EffectLeonor Côrte-Real, Brittany Karas, Ana Rita Brás, et al.
Pageof 4